featured-post-side

URMC's Kishan Pandya kicks off this season's “Hidden Passions: Inspiring Conversations about Hyphenated Lives,” a series sponsored by Memorial Art Gallery to showcase Rochesterians whose lives feature intriguing and unusual creative outlets.

The common fruit fly is often deemed an annoying household pest. But these tiny insects are a boon to researchers. Rochester biologist John Jaenike has co-authored the first comprehensive guide to fruit flies published in nearly a century.

When we think of research, many of us picture test tubes in a laboratory or manuscripts in a library. But some research projects—especially in the fields of health, education, and the social sciences—involve people as they go about their daily lives. How, then, can the University conduct community-engaged projects that are effective, evidence-based, and sustainable? Rochester students, researchers, and community members explored this question as part of the fifth annual Community Engagement Symposium.

The former Midnight Rambler is finding success on the London stage. Bat Out of Hell: The Musical makes its North American premiere in Toronto in October.

Optics professor Xi-Cheng Zhang has worked for nearly a decade to solve a scientific puzzle.

The University's first all-female Students' Association leadership team sits down with Quadcast host Peter Iglinski to talk about their plans for the 2017-17 academic year.

Students, faculty, and alumni take their unique perspectives on difficult and controversial conversations into the community as part of the annual arts fest.

Governor Andrew M. Cuomo yesterday announced $20 million in state support for the creation of a Rochester Data Science Consortium at the University of Rochester, with Harris Corporation as the consortium’s first partner.

Krystel Huxlin has developed rigorous visual training that can restore some of the basic vision lost to traumatic brain injury, stroke, or a tumor. Here Huxlin discusses how this therapy teaches undamaged parts of the brain to take over.

Researchers have identified a protein that is required for cell death after undergoing chemotherapy—at least, it appears, in male mice.